IBTimes -
19 Jan 2024 23:59
The study, led by Dr Trey Ideker, a professor in the Department of Medicine at UC San Diego School of Medicine, showcases the potential of artificial intelligence in unravelling the complexities of cancer drug responses.
Share this Article